Skip to Content
MilliporeSigma

BPS60381

PDE9A2 Assay Kit

Synonym(s):

Assay Kits, PDE9A

Select a Size

Change View

About This Item

UNSPSC Code:
41121811
Sign in to see your pricing
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorescence Polarization)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The PDE9A Assay Kit is designed for identification of PDE9A inhibitors using fluorescence polarization. The assay is based on the binding of a fluorescent nucleotide monophosphate generated by PDE9A to the binding agent. The key to the PDE9A Assay Kit is the specific binding agent. Using this kit, only two simple steps on a microtiter plate are required for PDE9A reactions. First, the fluorescently labeled cGMP is incubated with a sample containing PDE9A for 1 hour. Second, a binding agent is added to the reaction mix to produce a change in fluorescent polarization that can then be measured using a fluorescence reader.

Application

Study enzyme kinetics and screen small molecule inhibitors for drug discovery in high throughput screening (HTS) applications.
Phosphodiesterases (PDEs) play an important role in the dynamic regulation of the second messengers cAMP (cyclic adenosine monophosphate) and cGMP (cyclic guanosine monophosphate) signaling, by hydrolyzing them. The PDE superfamily is composed of 11 families, with PDE5 and PDE9 being cGMP-specific hydrolases, and thus regulating positive and negative responses to it. PDE9A2 is expressed in certain regions of the brain, where it plays a role in regulating synaptic transmission, learning, and memory. Its influence on cGMP levels can affect neuronal signaling. Since cGMP is a mediator in blood vessel relaxation, PDE9A2 has an impact on blood pressure regulation and overall vascular function.. Dysregulation of PDE9A2 may contribute to various conditions, including cardiovascular diseases, neurological disorders, and possibly cancer, as its activity influences cell signaling and growth. PDE9A2 is being explored as a target for drug development, particularly for neurological disorders like Alzheimer′s disease (AD), as modulating its activity can impact cognitive functions. Inhibiting PDE9A2 could increase cGMP levels, which may have beneficial effects in neurodegenerative diseases.
Datasheet and Protocols may be found here.

Features and Benefits

The PDE9A inhibitor screening assay kit comes in a convenient 96-well format, includingpurified PDE9A enzyme, fluorescently labeled PDE9 substrate (cGMP), binding agent,and PDE assay buffer for 100 enzyme reactions.


Pictograms

Corrosion

Signal Word

Danger

Hazard Codes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

WGK

WGK 2



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library